Location Lund, Skane Lan, Sweden Regions European Union (EU), Nordic Countries, Scandinavia Gender Female
LinkedIn View on LinkedIn
Ann Gidner has solid experience from senior positions in the pharmaceutical industry and life science. Her many years of experience includes roles as Head of the CTS Business Unit at Inceptua GmbH in Berlin, Licensing Director at Albumedix A/S (Novozymes Biopharma) and as CEO of the pharma strategy company Monocl AB. She has previous extensive
experience of global commercial responsibility in large international CMO corporations. Ann has built the business model and created strong sales growth at Cambrex Corporation with placement in Sweden and New Jersey, USA, and at Saltigo GmbH with placement in Germany. She is also a board member of SenzaGen AB since 2014.
